Emerging novel antifungal agents

被引:105
作者
Fostel, JM [1 ]
Lartey, PA [1 ]
机构
[1] Pharmacia & Upjohn Inc, Infect Dis Res, Kalamazoo, MI 49001 USA
关键词
D O I
10.1016/S1359-6446(99)01430-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Promising new compounds have recently been identified in an effort to supplement the relatively sparse portfolio of antifungal drugs. Many of these compounds have defined mechanisms of action against fungal cells and have, in some cases, aided the identification of new selective targets in fungi. For most of these compounds, however, factors such as a narrow spectrum of activity, susceptibility to efflux pumps, protein binding, serum inactivation and poor pharmaceutical properties prevent their use in the clinic. Even so, these compounds are novel substrates for synthetic modifications that could lead to the discovery of future antifungal drugs.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 52 条
[1]   Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanicum LL-15G256 [J].
Abbanat, D ;
Leighton, M ;
Maiese, W ;
Jones, EBG ;
Pearce, C ;
Greestein, M .
JOURNAL OF ANTIBIOTICS, 1998, 51 (03) :296-302
[2]   NEORUSTMICIN-A, A NEW MACROLIDE ANTIBIOTIC ACTIVE AGAINST WHEAT-STEM RUST FUNGUS [J].
ABE, Y ;
NAKAYAMA, H ;
SHIMAZU, A ;
FURIHATA, K ;
IKEDA, K ;
FURIHATA, K ;
SETO, H ;
OTAKE, N .
JOURNAL OF ANTIBIOTICS, 1985, 38 (12) :1810-1812
[3]   Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis [J].
Abruzzo, GK ;
Flattery, AM ;
Gill, CJ ;
Kong, L ;
Smith, JG ;
Pikounis, VB ;
Balkovec, JM ;
Bouffard, AF ;
Dropinski, JF ;
Rosen, H ;
Kropp, H ;
Bartizal, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2333-2338
[4]   GALBONOLIDE-A AND GALBONOLIDE-B - 2 NEW NON-GLYCOSIDIC ANTIFUNGAL MACROLIDES FROM STREPTOMYCES-GALBUS [J].
ACHENBACH, H ;
MUHLENFELD, A ;
ZAHNER, H .
TETRAHEDRON LETTERS, 1985, 26 (50) :6167-6170
[5]   Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanicum LL-15G256 -: III.: Biological properties of 15G256γ [J].
Albaugh, D ;
Albert, G ;
Bradford, P ;
Cotter, V ;
Froyd, J ;
Gaughran, J ;
Kirsch, DR ;
Lai, M ;
Rehnig, A ;
Sieverding, E ;
Silveriman, S .
JOURNAL OF ANTIBIOTICS, 1998, 51 (03) :317-322
[6]   Antifungal azoxybacilin exhibits activity by inhibiting gene expression of sulfite reductase [J].
Aoki, Y ;
Yamamoto, M ;
HosseiniMazinani, SM ;
Koshikawa, N ;
Sugimoto, K ;
Arisawa, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :127-132
[7]   A NEW METHIONINE ANTAGONIST THAT HAS ANTIFUNGAL ACTIVITY - MODE OF ACTION [J].
AOKI, Y ;
KONDOH, M ;
NAKAMURA, M ;
FUJII, T ;
YAMAZAKI, T ;
SHIMADA, H ;
ARISAWA, M .
JOURNAL OF ANTIBIOTICS, 1994, 47 (08) :909-916
[8]   TRANSLATION ELONGATION FACTOR-III - A FUNGUS-SPECIFIC TRANSLATION FACTOR [J].
BELFIELD, GP ;
TUITE, MF .
MOLECULAR MICROBIOLOGY, 1993, 9 (03) :411-418
[9]   Translation elongation factor 2 is part of the target for a new family of antifungals [J].
Capa, L ;
Mendoza, A ;
Lavandera, JL ;
de las Heras, FG ;
García-Bustos, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2694-2699
[10]   ANTICANDIDA ACTIVITY OF CISPENTACIN - THE ACTIVE-TRANSPORT BY AMINO-ACID PERMEASES AND POSSIBLE MECHANISMS OF ACTION [J].
CAPOBIANCO, JO ;
ZAKULA, D ;
COEN, ML ;
GOLDMAN, RC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (03) :1037-1044